Novartis Investigative site

Arhus N DK-8200

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease and Lipoprotein(a), IgA Nephropathy, Systemic Juvenile Idiopathic Arthritis

Studies at this site

• Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients — Completed
• Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
• Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA) — Stopped early